Echinococcosis, Hepatic Clinical Trial
Official title:
Laparoscopic Versus Open Conservative Surgery for the Management of Cystic Echinococcosis of the Liver: Prospective, Randomized, and Controlled Clinical Trial of Efficacy and Safety
Verified date | July 2012 |
Source | Medical Park Gaziantep Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | Turkey: Ethics Committee |
Study type | Interventional |
Echinococcosis in humans is a parasitic tapeworm infection, caused by a larval stage (the
metacestode) of Echinococcus species. The infection can be asymptomatic or severe, causing
extensive organ damage and even death of the patient.
Echinococcosis is one of the most neglected parasitic diseases and the lack of the
prospective randomised studies supports this idea. Development of new drugs and other
treatment modalities receives very little attention, if any. In most developed countries,
Cystic Echinococcosis (CE) is an imported disease of very low incidence and prevalence and
is found almost exclusively in migrants from endemic regions. In endemic regions,
predominantly settings with limited resources, patient numbers are high.
The aim of the hydatid cyst treatment is the death of the parasite and consequently the cure
of the disease. It has to be done with a minimal risk and maximum comfort for the patient,
and always paying attention to avoid complications, secondary hydatidosis, and relapses.
There are several treatment modalities. Of them the most preferred surgical method is
traditional cyst management through a laparotomy incision. Same can be done with
laparoscopy. In the past 15 years significant advances in laparoscopic surgical skills and
techniques combined with explosive advances in laparoscopic technology have encouraged the
application of laparoscopy to the evaluation and treatment of solid organs including the
liver. There are many studies about the laparoscopic treatment of liver hydatid cyst
published in the literature and the feasibility of this procedure has been demonstrated by
them. While the majority of them are case reports or case series, there are some relatively
large series comparing open versus laparoscopic surgery published in the last decade, which
all are not randomized trial.
Status | Completed |
Enrollment | 350 |
Est. completion date | May 2012 |
Est. primary completion date | November 2010 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 90 Years |
Eligibility |
Inclusion Criteria: - patients eighteen year-old or older - patients diagnosed as cystic echinococcosis of the liver - cyst number less then 3 - cyst size greater than 3 cm Exclusion Criteria: - previous liver surgery - recurrent disease - hydatid cyst with multi-organ involvement - liver hydatid cyst complicated with infection - contraindication for general anesthesia - contraindication for laparoscopic surgery - patient younger than 18 - allergy to albendazole |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Turkey | 25 Aralik State Hospital | Gaziantep | |
Turkey | Dr.Ersin Aslan State Hospital | Gaziantep | |
Turkey | Hatem Hospital | Gaziantep | |
Turkey | Medical Park Gaziantep Hospital | Gaziantep |
Lead Sponsor | Collaborator |
---|---|
Medical Park Gaziantep Hospital |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | cyst recurrence | 24 months | Yes | |
Secondary | mortality | 24 months | Yes | |
Secondary | intraoperative complications | 24 hours | Yes | |
Secondary | late complications | 24 months | Yes | |
Secondary | pain score | VAS scoring scale will be use | Post opertaive 6th hour, 1, 2, and 7th days | Yes |
Secondary | patient comfort/satisfaction | will be measured in all follow-up examinations using a scale from 0 (worst) to 10 (excellent). | 24 months | No |
Secondary | hospital stay | postoperative hospital days | 10 days | No |
Secondary | duration of the operation | from incision to closure of the skin | 240 minutes | No |
Secondary | quality of life | first week, 1, 6, 12, and 24 month after operation | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06316154 -
Presentation of Protoscolexes and Acephalocysts in the Fibrous Capsule Area of the Liver With Echinococcosis
|
||
Completed |
NCT01785212 -
The Influence of Two Different Hepatectomy Methods on Transection Speed and Chemokine Release From the Liver
|
N/A | |
Completed |
NCT05420155 -
Surgical Treatment of Liver Hydatid Cyst (SURGHIDA)
|
||
Recruiting |
NCT05090020 -
Hypernatremia in Hydatid Cyst Treatment
|